Name Bifidumbacterin dry.lyoph.por.d/app.susp.d/pr.in.and local.app.5 doses per vial in pack No. 10 taste. Marbling, the presence of uneven surfaces of the porous mass is allowed. in adults and children. For children (including premature babies), the drug can be used from the first days of life. Bifidumbacterin dry is used to restore microbiological balance in the intestines: in acute and chronic inflammatory diseases of the large and small intestines in children and adults, occurring against the background of microflora disorders with a deficiency of bifidobacteria; with intestinal dysfunctions after antibiotic and radiation therapy; in the complex therapy of patients with acute intestinal infections of a bacterial and viral nature, convalescents with symptoms of intestinal dysfunction, for the prevention of intestinal dysfunction during antibiotic therapy of children with pyoinflammatory diseases; for the prevention of intestinal dysfunctions in premature babies, as well as in children during the neonatal period with an early transfer to artificial feeding. Bifidumbacterin dry is used: to normalize vaginal microbiocenosis in the complex therapy of bacterial colpitis, including in pregnant women. Dosage and administration Bifidumbacterin dry for intestinal diseases is used orally, and in obstetric and gynecological practice intravaginally. Remove the metal cap and rubber stopper from the vial. The contents of the vial are dissolved with boiled water at room temperature at the rate of 1 teaspoon per 1 dose of the drug. Method of dissolution: the required amount of teaspoons of water is poured into a glass (in accordance with the number of doses indicated on the container label), then a small amount of water is transferred from the glass into the bottle to dissolve the dry mass. After dissolution, the contents of the vial are transferred to the same beaker and mixed. One teaspoon of the drug dissolved in this way constitutes one dose. The required number of doses (respectively, teaspoons) is drunk 20-30 minutes before meals. For infants, the drug can be given immediately before feeding. In intestinal diseases, the duration of the course of treatment with bifidumbacterin is determined by the severity of clinical manifestations, the age of the patient and is 2-4 weeks, and in some cases up to 3 months. For prophylactic purposes, 5 doses are prescribed 1-2 times a day for 1-2 weeks. For newborns of the "risk" group, it is advisable to start using the drug in the maternity ward from the first day of life until discharge, 1-2 doses per dose 3 times a day. In case of intestinal diseases in children of the first six months of life, the drug is prescribed 3 doses per dose 3 times a day. Children of the second half of the year and older - 5 doses 2 times a day. If children develop disorders of the gastrointestinal tract and the threat of ulcerative necrotic enterocolitis, up to 10 doses per day are prescribed. In acute chronic inflammatory diseases of the small and large intestines, colitis and enterocolitis in adults, 5 doses 2-3 times a day are recommended. In complex therapy with antibiotics and other antibacterial drugs, it is recommended: for children under 1 year old, 5 doses 2-3 times a day, for children over 1 year old, 5 doses 3-4 times a day, for adults, 10 doses 2-3 times a day. For intravaginal administration, bifidumbacterin is dissolved in the manner indicated above. The resulting suspension of the drug is impregnated with a sterile swab, which is administered intravaginally and left for 2-3 hours. In inflammatory gynecological diseases and prenatal preparation of pregnant women of the "risk" group, bifidumbacterin is prescribed 5-10 doses 1 time per day for 5-8 days under the control of restoring the purity of the vaginal secretion to I-II degree and the disappearance of clinical symptoms of inflammation. If necessary, the course of treatment with bifidumbacterin can be repeated. Use during pregnancy and lactationThe use of women during pregnancy and lactation is allowed. Precautions Do not dissolve the drug in hot water (above 40 °C). Do not store in solution. Use with caution in persons with lactose intolerance and cow's milk casein. No features of the use of the drug in persons with impaired liver and kidney function have been identified. Allowed for use by women during pregnancy and lactation. No features of application in gerontological practice have been identified. Does not affect the ability to drive vehicles and work with dangerous mechanisms. Interaction with other drugs There are no undesirable effects in the interaction of bifidumbacterin with other drugs. With the simultaneous use of bifidumbacterin with vitamins (especially group B), the effect of the drug is enhanced. When taken with antibiotics and chemotherapeutic drugs, the therapeutic efficacy of bifidumbacterin may decrease. Contraindications There are no contraindications for the use of the drug Composition of 5 doses of the drug. 1 dose of the drug contains: lyophilized in the cultivation medium of viable bacteria of the Bifidobacterium bifidum 1 or 791 strain - at least 107 CFU. The cultivation medium consists of yeast autolysate, casein enzymatic hydrolyzate, lactose monohydrate, sodium chloride, L-cystine, food agar, purified water. Overdose At present, no adverse effects have been reported in cases of drug overdose. Side effects There are no side effects. At the beginning of taking Bifidumbacterin dry, a temporary loosening of the stool is possible. In this case, the abolition of the drug is not required. Storage conditions In a place protected from light at a temperature of 2 ° C to 8 ° C. Keep out of the reach of children. Shelf life - 1 year. Do not use after the expiry date stated on the package. Buy Bifidumbacterin dry lyophilized powder for oral and topical suspension preparation 5 doses №10 Bifidumbacterin dry lyophilized powder for oral and topical suspension preparation 5 doses №10 and topical application 5 doses №10
US: temporary delays — postal services aligning new import rules, 
EU: 1–2 weeks, 🌍 Worldwide: 1–4 weeks ✈️